Primary Immune Deficiency Treatment Consortium (PIDTC) Anonymous (not verified) Wed, 02/27/2019 - 14:46
PIDTC
The PIDTC conducts multi-center studies of primary immune deficiency (PID) diseases and aims to expand the understanding and improve treatments and outcomes for patients with rare PIDs.
Brittle Bone Disorders Consortium pioneers Osteogenesis Imperfecta research and treatment Anonymous (not verified) Wed, 02/27/2019 - 14:07
BBD

Through research, the BBDC is discovering new biomarkers of the disease that will lead to a deeper understanding of underlying pathophysiology of OI as well as assessing response to therapies